Giovanni Brandi

17.4k total citations · 6 hit papers
254 papers, 9.8k citations indexed

About

Giovanni Brandi is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giovanni Brandi has authored 254 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Surgery, 131 papers in Oncology and 85 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giovanni Brandi's work include Cholangiocarcinoma and Gallbladder Cancer Studies (106 papers), Hepatocellular Carcinoma Treatment and Prognosis (61 papers) and Pancreatic and Hepatic Oncology Research (47 papers). Giovanni Brandi is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (106 papers), Hepatocellular Carcinoma Treatment and Prognosis (61 papers) and Pancreatic and Hepatic Oncology Research (47 papers). Giovanni Brandi collaborates with scholars based in Italy, United States and France. Giovanni Brandi's co-authors include Alessandro Rizzo, Angela Dalia Ricci, Simona Tavolari, Guido Biasco, Shahid A. Khan, Stefano Bellentani, Gioconda Saccoccio, Claudio Tiribelli, Lory Saveria Crocè and Flora Masutti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Giovanni Brandi

244 papers receiving 9.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

2009 1.1k citations Giovanni Brandi et al. profile →
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

2000 1.0k citations Giovanni Brandi et al. profile →
Cholangiocarcinoma: Epidemiology and risk factors

2019 497 citations Simona Tavolari, Giovanni Brandi et al. profile →
Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?

2015 292 citations Matteo Renzulli, Giovanni Brandi et al. profile →
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer

2021 199 citations Alessandro Rizzo, Angela Dalia Ricci et al. Cancers profile →
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions

2024 79 citations Giovanni Brandi, Simona Tavolari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giovanni Brandi Italy	53	3.5k	3.3k	2.9k	2.3k	1.9k	254	9.8k
Luís Bujanda Spain	52	3.4k 1.0×	2.5k 0.8×	2.8k 1.0×	1.7k 0.7×	1.5k 0.8×	330	9.6k
Cord Langner Austria	48	3.1k 0.9×	2.6k 0.8×	1.8k 0.6×	1.8k 0.8×	2.4k 1.3×	223	8.7k
Naoya Sakamoto Japan	49	2.1k 0.6×	1.8k 0.5×	2.6k 0.9×	1.6k 0.7×	2.6k 1.4×	442	9.5k
Gert De Hertogh Belgium	51	2.6k 0.7×	2.5k 0.8×	1.6k 0.6×	1.3k 0.6×	2.8k 1.5×	309	9.1k
Joo Sung Kim South Korea	53	5.0k 1.4×	1.7k 0.5×	1.8k 0.6×	3.1k 1.3×	2.1k 1.1×	411	11.1k
Jan H. Kleibeuker Netherlands	54	3.0k 0.9×	3.5k 1.1×	1.6k 0.5×	1.6k 0.7×	1.4k 0.7×	218	9.4k
Roland Andersson Sweden	49	4.2k 1.2×	4.0k 1.2×	2.0k 0.7×	1.7k 0.7×	1.1k 0.6×	377	9.2k
Jaw‐Town Lin Taiwan	45	2.9k 0.8×	1.2k 0.4×	1.1k 0.4×	2.0k 0.8×	2.2k 1.2×	150	7.1k
Hidetaka Mochizuki Japan	55	3.2k 0.9×	4.5k 1.4×	1.2k 0.4×	2.6k 1.1×	837 0.4×	231	9.0k
Achim Weber Switzerland	55	2.1k 0.6×	2.6k 0.8×	2.9k 1.0×	889 0.4×	2.0k 1.0×	213	9.0k

Countries citing papers authored by Giovanni Brandi

Since Specialization

Citations

This map shows the geographic impact of Giovanni Brandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Brandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Brandi more than expected).

Fields of papers citing papers by Giovanni Brandi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Brandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Brandi. The network helps show where Giovanni Brandi may publish in the future.

Co-authorship network of co-authors of Giovanni Brandi

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Brandi. A scholar is included among the top collaborators of Giovanni Brandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Brandi. Giovanni Brandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monte, Anne De, Alessandro Rizzo, Simona Tavolari, et al.. (2025). Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. International Journal of Molecular Sciences. 26(24). 11961–11961.

Malizia, Claudio, Gian Carlo Mattiucci, Francesco Cellini, et al.. (2024). Chemoradiation of locally advanced biliary cancer: A PRISMA‐compliant systematic review. Cancer Medicine. 13(23). e70196–e70196. 1 indexed citations

Rizzo, Alessandro, Oronzo Brunetti, & Giovanni Brandi. (2024). Hepatocellular Carcinoma Immunotherapy: Predictors of Response, Issues, and Challenges. International Journal of Molecular Sciences. 25(20). 11091–11091. 10 indexed citations

Ricci, Angela Dalia, Alessandro Rizzo, Rosalba D’Alessandro, et al.. (2024). Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications. Cancers. 16(20). 3542–3542. 4 indexed citations

Tavolari, Simona & Giovanni Brandi. (2023). Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review. Cells. 12(9). 1216–1216. 9 indexed citations

Rizzo, Alessandro, Angela Dalia Ricci, Annarita Fanizzi, et al.. (2023). Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis. Current Oncology. 30(1). 749–757. 5 indexed citations

Casadei‐Gardini, Andrea, Francesco Leone, Giovanni Brandi, et al.. (2023). Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy. Frontiers in Oncology. 13. 1128930–1128930. 1 indexed citations

Fabbri, Francesca, et al.. (2023). Improvements in Systemic Therapies for Advanced Malignant Mesothelioma. International Journal of Molecular Sciences. 24(13). 10415–10415. 5 indexed citations

Brandi, Giovanni & Alessandro Rizzo. (2022). IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?. International Journal of Molecular Sciences. 23(18). 10869–10869. 10 indexed citations

10.

Rizzo, Alessandro, Angela Dalia Ricci, Antonio Cusmai, et al.. (2022). Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future. Current Oncology. 29(2). 551–564. 5 indexed citations

11.

Brandi, Giovanni, Giuseppe Di Pasquale, P. De Carolis, et al.. (2021). Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology. BMJ Open. 11(5). e043239–e043239. 5 indexed citations

12.

Rizzo, Alessandro, et al.. (2020). Experimental HER2- targeted therapies for biliary tract cancer. Expert Opinion on Investigational Drugs. 30(4). 389–399. 11 indexed citations

13.

Galenkamp, Koen M.O., Paulina Sosicka, Michael Jung, et al.. (2020). Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells. Cancer Discovery. 10(6). 822–835. 39 indexed citations

14.

Brandi, Giovanni, Angela Dalia Ricci, Alessandro Rizzo, et al.. (2020). Is post‐transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?. Cancer Communications. 40(9). 461–464. 46 indexed citations

15.

Viza, D., et al.. (2020). Transfer Factor as an Option for Managing the COVID-19 Pandemic. Folia Biologica. 66(3). 86–90. 3 indexed citations

16.

Mollica, Veronica, Alessandro Rizzo, Rodolfo Montironi, et al.. (2020). Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma. Cancers. 12(6). 1449–1449. 71 indexed citations

17.

Lorenzo, Stefania De, Francesco Tovoli, Alessandro Mazzotta, et al.. (2020). Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. Cancers. 12(11). 3182–3182. 40 indexed citations

18.

Ravegnini, Gloria, Milena Urbini, Vittorio Simeon, et al.. (2018). An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor. The Pharmacogenomics Journal. 19(4). 390–400. 21 indexed citations

19.

Pantaleo, Maria A., Annalisa Astolfi, Margherita Nannini, et al.. (2007). Gene expression profiling differences between synchronous and metachronous liver metastases of colorectal cancer. Molecular Cancer Therapeutics. 6. 1 indexed citations

20.

Brandi, Giovanni, Maria A. Pantaleo, Carlo Calabrese, et al.. (2004). Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. International Journal of Colorectal Disease. 19(6). 599–602. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact